Peter Hunter
Corporate Officer/Principal chez Auckland University
Profil
Peter Hunter is currently the Director of Computational Physiology at the University of Oxford and the Director of the Bioengineering Institute at Auckland University.
He previously worked as a Commercialization Manager at eBonz Ltd.
in 2011.
Postes actifs de Peter Hunter
| Sociétés | Poste | Début |
|---|---|---|
| Auckland University | Corporate Officer/Principal | 07/06/2011 |
| University of Oxford | Corporate Officer/Principal | 07/06/2011 |
Anciens postes connus de Peter Hunter
| Sociétés | Poste | Fin |
|---|---|---|
eBonz Ltd.
 eBonz Ltd. Pharmaceuticals: OtherHealth Technology eBonz was a startup company from the Auckland Bioengineering Institute involved in the development of functional 3D anatomically based models of the joints in the human body. eBonz develop patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. These models can be used by orthopedic device and insurance companies, and for education and training of patients and surgeons. eBonz was established in 2007 to take orthopedic modeling to market. It was built upon extensive research at the Auckland Bioengineering Institute (ABI) in the field of computational biomechanics. The ABI has an international reputation for innovative research and successful commercialization of ideas. eBonz continues to have a very close working relationship with the ABI. eBonz developed patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
eBonz Ltd.
eBonz Ltd. Pharmaceuticals: OtherHealth Technology eBonz was a startup company from the Auckland Bioengineering Institute involved in the development of functional 3D anatomically based models of the joints in the human body. eBonz develop patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. These models can be used by orthopedic device and insurance companies, and for education and training of patients and surgeons. eBonz was established in 2007 to take orthopedic modeling to market. It was built upon extensive research at the Auckland Bioengineering Institute (ABI) in the field of computational biomechanics. The ABI has an international reputation for innovative research and successful commercialization of ideas. eBonz continues to have a very close working relationship with the ABI. eBonz developed patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. | Health Technology |